Company page

Nexalis Therapeutics Limited

Nexalis Therapeutics Limited, trading under the ticker NX1, is a public company based in Australia with a market capitalization of approximately AUD 2.3 million. The company focuses on developing innovative therapeutic solutions. As a publicly listed entity, Nexalis is committed to transparency and compliance with market regulations.